None listed
Conditions
Brief summary
This protocol aims to explore the potential effectiveness of topical eucalypt sap resin application across a range of both acute and chronic skin injury and inflammatory conditions, using this novel Australian native ingredient with antimicrobial, styptic, and astringent properties. Skin conditions to be evaluated as individual case studies under this protocol cover wound care (both acute and chronic), fungal skin infections, acne, insect bites and sunburn.
Interventions
Arm A - Eucalypt extract (C5-2024) in inert gel formulation
The treatment will be individualised as appropriate for each case and documented as individual case studies. The gel will be applied topically to affected skin area at a dose of 1mL per cm2. For all wound presentations, the product will be applied by a wound care nurse in a medical clinic, in accordance with standard wound management guidelines appropriate for the type of wound, i.e. application and re-dressing every 7 days or as requi
Arm A - Eucalypt extract (C5-2024) in inert gel formulation The treatment will be individualised as appropriate for each case and documented as individual case studies. The gel will be applied topically to affected skin area at a dose of 1mL per cm2. For all wound presentations, the product will be applied by a wound care nurse in a medical clinic, in accordance with standard wound management guidelines appropriate for the type of wound, i.e. application and re-dressing every 7 days or as required. For all other conditions, the product will be applied by the participant themselves in their home environment. Adherence and overall usage of test product will be checked by monitoring of remaining gel amounts.
Sponsors
Integria Healthcare (Australia) Pty Ltd.
Study design
Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
Adult males and females Presence of inflammatory skin condition or wound
Exclusion criteria
- Pregnant, planning pregnancy or breastfeeding - Any clinically relevant abnormal findings which, in the opinion of the Investigators may put the participant at risk of adverse events due to participation in clinical trial. - Use of any topical or oral anti-microbial, anti-fungal, anti-acne, or steroid medicated treatments in the previous 3 days
Outcome results
None listed